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Abstract
Background—Although direct medical costs for constipation-related medical visits are thought
to be high, to date there have been no studies examining if longitudinal resource utilization is
persistently elevated in children with constipation. Our aim was to estimate the incremental direct
medical costs and types of health care utilization associated with constipation from childhood to
early adulthood.
Methods—A nested case-control study was conducted to evaluate the incremental costs
associated with constipation. The original sample consisted of 5,718 children in a population-
based birth cohort who were born during 1976–1982 in Rochester, MN. The cases included
individuals who presented to medical facilities with constipation. The controls were matched and
randomly selected among all non-cases in the sample. Direct medical costs for cases and controls
were collected from the time subjects were between 5–18 years of age or until the subject
emigrated from the community.
Results—We identified 250 cases with a diagnosis of constipation in the birth cohort. While the
mean inpatient costs for cases were $9994 (95% CI=2538, 37201) compared to $2391 (95%
CI=923, 7452) for controls (p=0.22) over the time period, the mean outpatient costs for cases were
$13927 (95% CI=11325, 16525) compared to $3448 (95% CI=3771, 4621) for controls (p<0.001)
over the same time period. The mean annual number emergency department visits for cases were
0.66 (95% CI=0.62, 0.70) compared to 0.34 (95% CI=0.32, 0.35) for controls (p<0.0001).
Conclusion—Individuals with constipation have higher medical care utilization. Outpatient
costs and ER utilization were significantly greater for individuals with constipation from
childhood to early adulthood.
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Chronic constipation is a common and heterogeneous disorder, which is often characterized
by difficult, infrequent stool passage, or incomplete evacuation. 1–3 Population-based studies
have estimated the prevalence of chronic constipation in North America varies between 2%
and 27% of children and adults, leading to at least 2.5 million physician visits annually in
the United States. 1–7 In a recent database analysis by Everhart et al.8 on the burden of
digestive diseases in the United States, constipation was the second most common
ambulatory care diagnosis, after gastroesophageal reflux disease (GERD).
Chronic constipation is one of the most common reasons for ambulatory care visits by
children.9–12 In young children (birth to 5 years), incident medical visits (first time visits)
for constipation were among the highest for all the gastrointestinal disorders including
GERD and abdominal pain of unknown origin.13 The incidence of medical presentation for
children with constipation has also been observed to be substantially higher than other
chronic episodic pediatric conditions (for example, 7 times higher than asthma in children
7–8 years of age and 3 times higher than migraine headaches in children 10–14 years of
age)10, 11
No studies have examined longitudinal resource utilization in children and adults with
constipation in the community.14 Utilizing a national disease and therapeutic index database,
Sonnenberg et al.9 estimated that ambulatory visits for constipation resulted in annual costs
of $29 million (1985 value). In recent review,8 5.4 million prescriptions were filled for
constipation according to the Verispan database of retail pharmacy, but the data did not
capture the very large number of nonprescription medications purchased for constipation.
Childhood constipation is often a relapsing chronic condition; children may present
repeatedly for constipation over a prolonged period of time. In a longitudinal follow-up
study of childhood constipation, van Ginkel et al. 15 showed that constipation was still
present in 30% of children after puberty despite medical therapy. Disease chronicity may
contribute to an increased number of outpatient visits, diagnostic evaluations, and inpatient
admissions in these people. However, none of the previous studies have been able to
evaluate the long-term costs and utilization associated with a diagnosis of constipation. A
better understanding of long-term resource utilization may help practitioners and health
systems develop strategies to optimally manage these patients. The aim of the present study
was to estimate the incremental direct medical costs and type of health care associated with
constipation from childhood through early adulthood.
METHODS
Setting
Olmsted County, Minnesota, is a metropolitan and rural area 90 miles southeast of
Minneapolis, Minnesota. Census data from the 1990 population, representing the years the
children from this birth cohort were in school, indicated the population was 70,745 (75%
were age < 45 years), and was estimated to be 96% Caucasian; sociodemographically, the
community is very similar to the United States Caucasian population.16, 17 Over 95% of
County residents receive their medical care from one of the two group practices in the
community (Mayo Medical Center and Olmsted Medical Center). Mayo Clinic has
maintained a common medical record system with its two affiliated hospitals (Saint Marys
and Rochester Methodist) for over 90 years. 16, 17 Recorded diagnoses and surgical
procedures are indexed, including the diagnoses made for outpatients seen in office or clinic
consultations, emergency room visits or nursing home care, as well as the diagnoses
recorded for hospital inpatient, at autopsy examination or on death certificates. This system
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was further developed by the Rochester Epidemiology Project (REP), which created similar
indices for the records of other providers of medical care to local residents, most notably the
Olmsted Medical Center and its affiliated Olmsted Community Hospital. Thus, details of the
medical care provided to the residents of the County are available for study. Annually, over
80% of the entire population is attended by one or both of these two practices, and nearly
everyone is seen at least once during any given 3-year period.16 Therefore, the Rochester
Project medical records linkage system also provides what is essentially an enumeration of
the population from which samples can be drawn.
Identification of the 1976–1982 Rochester Birth Cohort
As approved by the Institutional Review Boards of the Mayo Clinic and Olmsted Medical
Center, we used this system previously to draw a birth cohort consisting of all children born
between January 1, 1976, and December 31, 1982, to mothers residing in Olmsted County,
Minnesota, comprising the Minnesota Independent School district 535 (N = 8548) in the city
of Rochester.18 Subjects were identified through computerized birth certificate information
from the Minnesota Department of Health, Division of Vital Statistics. The vital status of
each member of the birth cohort during the 1995–1996 school year were established using
resources from the Rochester Epidemiology Project, Independent School District 535, and
the Minnesota Department of Health. The target population of this study consisted of 5718
children, who at or after the age of 5 years all still lived in Rochester and whose family did
not deny research authorization. A review of hospital and school records indicated that 80%
of the target population continued to reside in the area until at least age 18 years.
Identification of cases with constipation from age 5 to younger than 21 years in the 1976–
1982 birth cohort
Through the Rochester Epidemiology Project, all diagnoses and surgical procedures
recorded at Rochester medical facilities are indexed continuously for automated retrieval.
This diagnostic index expedites retrieval of the unit (or dossier) medical record, which
includes the history of all encounters in the hospital, community and ambulatory medical
and social services, emergency department, outpatient clinics, and home visits, as well as
laboratory and psychologic test results from birth until patients no longer reside within the
community.
Case ascertainment—All birth cohort members diagnosed with constipation from 5 to
younger than 21 years were identified by the following. Potential cases of constipation were
identified using the diagnostic index developed by the Rochester Epidemiologic Projects
(REP). The potential cases from 5 to younger than 21 years were identified as having one or
more of the following diagnostic or surgical codes, out of all birth cohort members:
constipation, H-ICDA-8 05640112 or ICD-9 564; obstipation, H-ICDA-8 05640111;
encopresis, H-ICDA-8 03167110 or ICD-9 307.7; unspecified functional disorder of
intestine, ICD-0 564.9. The diagnostic index was designed to be sensitive and thus this
broad search should capture all clinically diagnosed cases. However, a detailed chart review
was undertaken to improve specificity and ensure these cases actually had constipation.
Individuals were designated as cases with a diagnosis of constipation if they met the
following criteria from the chart abstraction: (1) HICDA or ICD-9 diagnosis, and (2) chart
review confirmed the medical visit was primarily for constipation, even if other
gastrointestinal symptoms were reported.
All children with a recognized or underlying disorder that would contribute to their
gastrointestinal symptoms at the time of the visit from the chart review such as cerebral
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palsy, developmental delay, a metabolic disorder, intestinal malformation or obstruction,
Hirschsprung’s disease, intestinal allergy, or inflammation were excluded from this study.
Data collection—Detailed information about the data collection has been previously
described.12, 13 The medical records of all potential incident cases with a medical visit for
constipation from 5 to younger than 21 years of age were reviewed using a standardized
chart review instrument.12, 13 Information regarding the date of the initial visit and the
presence of a medical visit for constipation in the chart was used to confirm the data from
the search of the administrative diagnostic index. Data concerning the demographic
characteristics, presenting complaints, and specific medical complaints and accompanying
gastrointestinal symptoms leading to the diagnosis were abstracted from the medical record.
In addition, detailed sociodemographic factors were collected at birth in the 1976–1982 birth
cohort. To determine factors that may influence medical presentation for a condition, birth
certificate information, including parental demographic characteristics, was evaluated. This
information was available from the computerized birth certificate information obtained from
the Minnesota Department of Health, Division of Vital Statistics. The specific information
evaluated included whether or not the child was born to a single parent, maternal age, and
maternal level of education. The selected comorbidities in cases and controls were defined
as the occurrence of at least one diagnosis within the time frame of the study (table 1); the
comorbidities were selected based on our a priori expectation that they could have an
impact on constipation status and medical costs, as well as being prevalent in children,
including the common cold, chronic sinusitis, otitis media, and influenza. Among the
selected comorbid conditions, we excluded conditions which did not have measurable
counts for calculating the medical costs.
Age- and Sex-Matched Controls
For each identified and reviewed case, we randomly selected 2 sex- and age-matched
controls from the pool of subjects in the birth cohort who did not have one of the relevant
HICDA or ICD-9 diagnoses for constipation. The controls were matched on gender and date
of birth (± 6 month) using an optimal matching algorithm applied to the values of each
matching factor.
Cost and Utilization Data
Beginning in January 1987, resource use and associated charges data from Mayo Clinic and
Olmsted Medical Center were collected. This claims-based database contains information on
medical resource utilization, associated charges, and estimated economic costs for patients
receiving care at either the Olmsted Medical Center or the Mayo Clinic and their associated
inpatient facilities. The Olmsted County Healthcare Expenditure and Utilization Database
(OCHEUD) provides a standardized inflation-adjusted estimate of costs for each service or
procedure provided locally in constant dollars. Specifically, using a “bottom-up” (also
referred to as micro-costing) costing approach, OCHEUD groups resource utilization into
the Medicare Part A and B classification system. Part A billed charges are adjusted by using
hospital cost-to-charge ratios and Part B physician services are valued by using Medicare
reimbursement rates.
Although the services provided represent the clinical practice patterns of Mayo Clinic and
Olmsted Medical Center providers, the value of each unit of service has been adjusted to
national norms by use of widely accepted valuation techniques.19 OCHEUD provides an
estimated economic cost for each line item in the billing record and allows the aggregation
of costs into categories deemed relevant to a particular study.19
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We present descriptive statistics on baseline factors (e.g. age, gender, proportion of cesarian
births, etc) as well as sociodemographic factors (e.g. mother’s education level, age of mother
at birth of child, etc.) for both the mothers and children. All categorical descriptive variables
are presented with both a count and percentage for both the controls and cases and were
compared using the Chi-Square test statistic. Continuous variables are described using the
mean and the standard deviation; comparison between the controls and cases was done using
the Wilcoxon Rank Sum test.
The incremental costs associated with constipation were assessed during the year that all
children were age 10, 13, and 16. We used 2-part models to estimate these costs so that we
accounted for the $0 cost in the population.20 For the 2-part model specifications, logistic
regression was used in part 1 to estimate the probability of costs conditional on patient
characteristics; Part 2 employed an inverse Gaussian distribution function with log link in
cost models. The specifications for the second part were determined using the modified Park
test as recommended by Manning and Mullahy.20 For the given ages none of the
comorbidities that were diagnosed during the given year of the specified age were
significant in predicting costs.
The Tian & Huang21 method was used to assess the overall mean estimated cost. It is a two
part model for censored medical costs due to loss to follow-up which also will account for
zero costs over the time frame. The first part assumes a parametric model, in this case
logistic regression to examine the association between positive medical costs from age 5 to
21 or loss to follow up adjusting for constipation or not. The second part uses a generalized
linear model with a gamma distribution and a log link for the positive costs. The censoring
caused by incomplete follow up is addressed by applying the inverse probability weighting
method to the two part model. This method allows for testing to see if a covariate has any
effect on the total medical costs as well an estimation of the mean medical costs for
individuals.
Similarly, this two-part model was employed to evaluate the predictors of costs within a
multivariate model for those patients with constipation. Each comorbidity that contained
measurable counts was entered into the model predicting outpatient, inpatient and total
costs. For each variable entered into the model, an estimate of the percentage change in costs
associated with each clinical characteristic is generated, contingent upon whether patients
have positive costs. However, one patient (0.4%) did not have a positive value for total costs
and outpatient costs in the cohort, and 120 (48%) had no inpatient costs.
All calculated p-values were two-sided and p-values less than 0.05 were considered
statistically significant. Statistical analyses was performed using SAS (SAS Institute, Cary,
NC) and R - General (R Development core Team (2008)) software packages.22
RESULTS
By 5 years of age, 5718 children were still living in the community. Of these, 5506 subjects
had not denied research authorization at the time of the study and were eligible for this
study. Among 5506 subjects at risk, a total of 250 incident subjects with a medical diagnosis
of constipation were identified. The mean age at the time of the initial visits was 11 years (±
4.2). The overall incidence rate for presenting with a diagnosis of constipation in children
from 5 to 21 years was 45 (95% CI, 40 – 51) per 1000 persons-years.
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Table 2 summarizes the sociodemographic characteristics in subjects with and without
constipation including parental demographics. Compared with age- and sex- matched
controls from the same birth cohort, there were no significant differences for the presence of
parental sociodemographic factors (single parent, maternal age, education level, the
proportion of constipation, and existing psychologic conditions), aside from a higher rate of
maternal somatization in children who later presented with constipation.
Prevalence of selected comorbidities
Table 3 summarized the distribution of the selected comorbidities in subjects with
constipation and without constipation. Of subjects with constipation, 19.2% received no
medical care for 1 of the selected comorbidities compared with 42.2% of the matched
control sample (p < .0001). Similarly, subjects with constipation were more likely to have
been treated for 2 or more of the selected comorbidities than the matched controls (60.8%,
vs. 31.4%; p <.0001). Specifically, children with constipation were more likely to present
with gastrointestinal, somatic and psychological, or respiratory conditions compared to
controls (table 3).
Medical visits and costs
The number of annual medical visits and annual costs of subjects with constipation from 5 to
21 years of age versus controls is summarized in table 4. On average, subjects with
constipation used more of all types of medical services than their matched controls.
Emergency department visits were the most frequently used type of services by subjects
with constipation, followed by outpatient care and inpatient care. More subjects with
constipation utilized hospital outpatient and inpatient as well as emergency department care
compared with matched controls. Notably, the mean annual number of emergency
department visits for subjects with constipation were 0.66 compared to 0.34 for controls
(p<0.0001) (table 4).
The mean direct medical costs for cases were four times those of controls over the time
period ($25100 vs. $5913; p=0.055). The mean inpatient costs for cases over the time period
were $9994 compared to $2391 for controls (p=0.22), while the mean outpatient costs over
the same time period for cases were $13927 compared to $3448 for controls (p=<0.001)
(table 4).
Figure 1 shows the total annual observed costs of subjects with constipation and without
constipation according to age. Overall, subjects with constipation consistently had higher
health care costs from childhood to early adulthood. Figure 2 shows the annual observed
outpatients medical costs for subjects with constipation versus controls. Total annual
medical costs for children to young adults with constipation were approximately twice that
of controls (primarily outpatient).
Interactions between constipation status and each comorbidity condition were examined for
total, inpatient medical costs and outpatient medical costs. There were no significant
interactions between constipation status and comorbid conditions for estimating medical
costs.
Influence of comorbid conditions on medical costs for patients with constipation
After adjusting for other factors, depression and otitis media were significantly associated
with both total and outpatient medical costs for patients with constipation (Table 5). Anxiety
was found to be significantly associated with all cost categories, generating a 348% increase
Choung et al. Page 6













in inpatient costs for patients with constipation (table 5). Patients with headaches had
increased inpatient costs but this did not significantly impact total costs.
Abdominal pain, influenza, and asthma, while not associated with total medical costs, were
significantly associated with lower inpatient medical costs for patients with constipation.
DISCUSSION
In this study, the overall incidence of a clinical diagnosis of constipation in children aged
between 5 and 21 years of age in Olmsted County, MN was estimated to be 45 per 1000
person years. We observed that subjects with a diagnosis of constipation consistently have
higher health care costs from childhood to early adulthood. Moreover, the overall annual
medical costs for children with constipation are approximately twice that of controls. This is
the first population based longitudinal study we know of to present US data on the costs
related with constipation from childhood to young adulthood compared to controls. In
particular, the costs for patients with constipation were higher compared with matched
controls for ambulatory care.
Arguably, constipation has not received the public health attention it deserves, especially in
children. von Ginkel et al.15 showed that one third of children with constipation still
experience constipation in adolescence. In adults, symptoms of constipation persist over a
prolonged period of time, and are likely a reason for repeated medical consultation23; Talley
et al. determined that in the general population, 89% of adults surveyed reported no change
in their bowel symptoms during an intervening 12–20 month period 23. In addition, Chitkara
et al.12 showed that children with a diagnosis of constipation at younger than 5 years of age
had about a 2 to 5 times higher incidence of subsequent medical visits for constipation
through adolescence and early adulthood compared with the incidence rate among children
without an early medical presentation. Therefore, children and adults may present repeatedly
for constipation over a prolonged period of time, and this likely contributes to the
incremental costs of health care utilization. In our study, children with constipation used
more of all types of medical services from 5 years to adolescence. It is difficult to estimate
the pure medical costs driven by chronic constipation, excluding the medical costs of any
associated comorbid conditions. We did assess the influence of comorbidity on medical
costs, and observed that otitis media, depression and anxiety had a significant impact on the
total medical costs. More specifically, anxiety was associated with a 184 % increase in total
medical costs, compared with depression that had a 97% increase and otitis media an 83%
increase in total medical costs. Thus it is conceivable that comorbid conditions in children
with constipation do increase health care utilization and induce higher total medical costs
compared to those not so affected.
Liem et al.24 studied the health utilization and cost impact of childhood constipation in the
United States using the Medical Expenditure Panel Survey (MEPS) database. In this study,
they showed that children with constipation used more health services than children without
constipation, resulting in significantly higher costs: $3430/year vs. $1099/year. This
amounts to an additional cost for children with constipation of $ 3.9 billion/year. This study
had some limitations; for example, the medical condition data in the MEPS were only
derived from parental reports, and the study was cross-sectional. The present study has
determined the incremental medical costs of childhood constipation with longitudinal
observations over 15 years. In our study, total incremental costs per year for subjects with
constipation were $630 and incremental costs of outpatient care per year for subjects with
constipation were $359, both highly significant compared with matched controls. More
interestingly, we found that subjects with a diagnosis of constipation consistently had higher
health care costs from childhood to early adulthood. Although direct comparisons are not
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possible due because no similar data exit, other studies have shown comparable high cost
burdens of chronic disease. The incremental total expenditure associated with asthma in
children versus without asthma was $1,004.6 in 2004.25 Another study26 using 1996
Medical Expenditure Panel Survey data showed that the incremental total medical costs
were $479 for children with Attention-Deficit/Hyperactivity Disorders, and $437 for
children with asthma. Notably, because we could not look at indirect costs, such as missed
school days due to illness or parents’ workday absences due to their child’s illnesses, much
higher incremental costs associated with constipation may exist.
This study had some potential limitations. First, we did not include all subjects with
constipation in the community, because subjects could have had mild symptoms not serious
enough to present for medical attention. Thus, our study more likely underestimates the
actual burden of childhood constipation. Furthermore, we cannot account for decreased
quality of life, nontraditional therapeutic interventions, and over-the-counter drugs such
laxatives, and the costs associated with undiagnosed patients with constipation were not
included in this study. Second, these data may be generalized to only the white US
population because the racial composition of this community is predominantly Caucasian.16
Moreover, the services and the utilization patterns in Olmsted County may not be
completely generalizable to other settings due to a higher proportion of the working
population employed in the health-care industry, and the correspondingly slightly higher
education level. Because our study compared subjects with and without constipation in an
attempt to demonstrate whether health-care utilization and the direct medical costs are
equivalent in both groups, however, at least it is reasonable to conclude that childhood
constipation induces significant incremental costs.
Thus, we conclude that children with constipation consistently experience higher overall
healthcare utilization, higher outpatient costs and more emergency department visits from
childhood through early adulthood. Management strategies need to consider addressing
these issues.
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The mean observed annual total costs for constipation. Each bar represents the mean
observed annual total medical costs for children with constipation versus controls according
to age.
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The mean observed annual outpatient costs for constipation. Each bar represents the mean
observed annual outpatient costs of children with constipation versus controls according to
age.
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Table 1
Medical indexes of the selected comorbid conditions (ICD-9 codes and HICDA codes)
Disease H-ICDA codes ICD-9 codes
GI disease
     GERD or heartburn 05300213, 07817110 530.1, 787.1
     Dyspepsia 05369121 536.8
     Abdominal pain 07800240 789.0
     Peptic ulcer disease 05330110, 05331112 533. x
     Irritable bowel syndrome 05641000, 05641110 564, 564.1
Non-GI disease
     Headache, tension or migraine 03460121, 03461310, 03168110, 06268120, 07920110, 07920114 784.0, 307.81, 346, 625.4, 784.0
     Thyroid disorder 02450112, 02459130, 02400410, 02442111, 02451310, 02449120 245, 240.9, 244.2
     Diabetes mellitus 02500110, 02500117, 02500118 250.0
     Depression 03082210, 03089111, 03082111 296.2x, 296.89, 298.0, 300.4, 311
     Anxiety 03100110, 03100120, 03100210 300.00, 300.02, 300.09, 309.21
     Influenza 04700000, 047001xx, 047003xx, 04700510, 047009xx 487.xx
     Otitis Media 03819000, 038191xx, 03819211 381.xx
     Asthma 04939000, 049391xx 493.xx
GERD=gastroesophageal reflux disease
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Follow up years, Mean (± SD) 13.4 (2.1) 13. (2.4) 0.17
Age at diagnosis, mean age (± SD) 11.6 (± 4.2) 11.1 (± 4.2) 0.99
Gender (matched)
   Boys 106 (42.4%) 212 (42.4%)
   Girls 144 (57.6%) 288 (57.6%)
Proportion of Cesarean delivery 28 (11.2%) 54 (10.8%) 0.87
Maternal factor
   Non legitimate birth (out of wedlock) 25 (10.0% 43 (8.6%) 0.53
   Maternal age at child’s birth, ≤ 18 y 12 (4.8%) 15 (3.0%) 0.21
   Maternal age at birth, mean age (± SD) 26.4 (5.0) 27.0 (4.8) 0.13
   Maternal education level at child’s birth
   < High school 91 (42.4%) 153 (35.4%) 0.09
   Maternal medical presentation
     Diagnosis of functional GI 128 (51.2%) 202 (40.4%) 0.005
   Constipation 0 2 (0.4%) 1.0
   Other FGIDs 21 (9.0%) 27 (5.7%) 0.11
   Somatization 33 (14.2%) 37 (7.9%) 0.009
   Psychologic condition (anxiety, depression) 14 (6.0%) 19 (4.0%) 0.25
FGIDs = functional gastrointestinal disorders
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Table 3
Prevalence of selected comorbidities for subjects with constipation versus controls





2 or more comorbidities 152 (60.8%) 157 (31.4%) <.0001
GI disease 128 (50.8%) 104 (20.8%) <.0001
     GERD or heartburn 15 (6.0%) 6 (1.2%) 0.0002
     Dyspepsia 8 (3.2%) 5 (1.0%) 0.03
     Abdominal pain 119 (47.6%) 96 (19.2%) <.0001
     Peptic ulcer disease 0 2 (0.4%) 0.56
     IBS 12 (4.8%) 9 (1.8%) 0.0189
Non GI disease 181 (72.4%) 267 (53.4%) <.0001
     Headache, tension or migraine 74 (29.6%) 77 (15.4%) <.0001
     Depression 63 (25.2%) 73 (14.6%) 0.0004
     Anxiety 29 (11.6%) 17 (3.4%) <.0001
     Thyroid disorder 3 (1.2%) 5 (1.0%) ~1
     Diabetes mellitus 1 (0.4%) 5 (1.0%) 0.67
     Influenza 26 (10.4%) 18 (3.6%) 0.0002
     Otitis Media 129 (51.6%) 192 (38.4%) 0.0006
     Asthma 53 (21.2%) 63 (12.6%) 0.0021
GERD=gastroesophageal reflux disease
IBS = irritable bowel syndrome
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Table 4






Non-users (1987–2003 Mayo utilization), n (%) 1 (0.4%) 46 (9.2%) <.0001
# of Patients with an Out Patient Visit(s) 163 (65.2%) 265 (53.0%) 0.0015
# of Patients with a Hospitalization(s) 130 (52.0%) 208 (41.6%) 0.007
# of Patients with a ER Visit(s) 241 (96.4%) 401 (80.2%) <.0001
Hospital inpatient stays per year, mean (± SD) 0.13 (0.59) 0.07 (0.41) <.0001
Hospital outpatient visits per year, mean (± SD) 0.16 (1.06) 0.11 (0.58) <.0001
ER visits per year, mean (±SD) 0.66 (1.25) 0.34 (0.85) <.0001












































Adjusted by Case vs. Control only.
3
Adjusted by Case vs. Control & mother’s diagnosis of functional GI
4
CI calculating using bootstrap method
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